To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
TrialJectory seals $2.7 mln seed
New York City-based TrialJectory, an AI-powered technology platform that uses self-reported clinical data to match cancer patients with clinical trials, has secured $2.7 million in seed financing.
